Hepatitis B Market
According to Intent Market Research, the Hepatitis B Market is expected to grow from USD 3.8 Billion in 2024-e at a CAGR of 4.4% to touch USD 4.9 Billion by 2030. The Hepatitis B Market is dominated by key players such as, Gilead Sciences, Johnson & Johnson, Merck & Co., Inc., Bristol-Myers Squibb, Roche Holding AG, and Abbott Laboratories.